These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10632831)

  • 1. The cost-effectiveness of different management strategies for patients on chronic warfarin therapy.
    Lafata JE; Martin SA; Kaatz S; Ward RE
    J Gen Intern Med; 2000 Jan; 15(1):31-7. PubMed ID: 10632831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation clinics and patient self-testing for patients on chronic warfarin therapy: A cost-effectiveness analysis.
    Lafata JE; Martin SA; Kaatz S; Ward RE
    J Thromb Thrombolysis; 2000 Jun; 9 Suppl 1():S13-9. PubMed ID: 10859580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing.
    Meckley LM; Gudgeon JM; Anderson JL; Williams MS; Veenstra DL
    Pharmacoeconomics; 2010; 28(1):61-74. PubMed ID: 20014877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-driven activity-based cost analysis for outpatient anticoagulation therapy: direct costs in a primary care setting with optimal performance.
    Bobade RA; Helmers RA; Jaeger TM; Odell LJ; Haas DA; Kaplan RS
    J Med Econ; 2019 May; 22(5):471-477. PubMed ID: 30744455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US.
    Sullivan PW; Arant TW; Ellis SL; Ulrich H
    Pharmacoeconomics; 2006; 24(10):1021-33. PubMed ID: 17002484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a new method of warfarin management on patient satisfaction, time, and cost.
    Meyer S; Frei CR; Daniels KR; Forcade NA; Bussey M; Bussey-Smith KL; Bussey HI
    Pharmacotherapy; 2013 Nov; 33(11):1147-55. PubMed ID: 24038425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. At-Home Versus In-Clinic INR Monitoring: A Cost-Utility Analysis from The Home INR Study (THINRS).
    Phibbs CS; Love SR; Jacobson AK; Edson R; Su P; Uyeda L; Matchar DB;
    J Gen Intern Med; 2016 Sep; 31(9):1061-7. PubMed ID: 27234663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivaroxaban vs. warfarin on extended deep venous thromboembolism treatment: A cost analysis.
    Diken AI; Yalçınkaya A; Hanedan MO; Erol ME; Ercen Diken Ö
    Phlebology; 2018 Feb; 33(1):53-59. PubMed ID: 28056701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of patient self-testing therapy of oral anticoagulation.
    Kantito S; Saokaew S; Yamwong S; Vathesatogkit P; Katekao W; Sritara P; Chaiyakunapruk N
    J Thromb Thrombolysis; 2018 Feb; 45(2):281-290. PubMed ID: 29181693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
    Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
    Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.
    Hall D; Buchanan J; Helms B; Eberts M; Mark S; Manolis C; Peele P; Docimo A
    Pharmacotherapy; 2011 Jul; 31(7):686-94. PubMed ID: 21923456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic-guided selection of warfarin versus novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: a cost-effectiveness analysis.
    You JH
    Pharmacogenet Genomics; 2014 Jan; 24(1):6-14. PubMed ID: 24168919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist.
    Carles M; Brosa M; Souto JC; Garcia-Alamino JM; Guyatt G; Alonso-Coello P
    BMC Health Serv Res; 2015 Jul; 15():289. PubMed ID: 26215871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of the pharmacist-assisted warfarin monitoring program at a Medical Center in Taiwan.
    Chang JY; Wang CC; Kang HC; Shen LJ; Huang CF
    Int J Qual Health Care; 2017 Oct; 29(6):817-825. PubMed ID: 29025143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic costs of routine INR monitoring in infants and children--examining point-of-care devices used within the home setting compared to traditional anticoagulation clinic monitoring.
    Gaw JR; Crowley S; Monagle P; Jones S; Newall F
    Thromb Res; 2013 Jul; 132(1):26-31. PubMed ID: 23746471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada.
    Quon P; Le HH; Raymond V; Mtibaa M; Moshyk A
    J Med Econ; 2016 Jun; 19(6):557-67. PubMed ID: 26761644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand.
    Saokaew S; Permsuwan U; Chaiyakunapruk N; Nathisuwan S; Sukonthasarn A; Jeanpeerapong N
    Thromb Res; 2013 Oct; 132(4):437-43. PubMed ID: 24041634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control.
    Janzic A; Kos M
    Pharmacoeconomics; 2015 Apr; 33(4):395-408. PubMed ID: 25512096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study.
    Menzin J; Boulanger L; Hauch O; Friedman M; Marple CB; Wygant G; Hurley JS; Pezzella S; Kaatz S
    Ann Pharmacother; 2005 Mar; 39(3):446-51. PubMed ID: 15701783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack.
    Kamel H; Johnston SC; Easton JD; Kim AS
    Stroke; 2012 Mar; 43(3):881-3. PubMed ID: 22308255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.